Switch to:
More From Other Websites
AVEO Pharmaceuticals (AVEO) Down 17.4% Since Earnings Report: Can It Rebound? Apr 24 2017
AVEO Announces Presentations at the 2017 ASCO Annual Meeting Apr 20 2017
AVEO Announces Submission of Response to Tivozanib Marketing Authorization Application Day 180 List... Apr 13 2017
AVEO Announces Milestone Payment from CANbridge for AV-203 Apr 03 2017
AVEO Announces Closing of Public Offering and Full Exercise of Option to Purchase Additional Shares Mar 31 2017
GGP, CenturyLink Drop into Tuesday’s 52-Week Low Club Mar 28 2017
AVEO Announces Pricing of $15.0 Million Public Offering of Common Stock Mar 28 2017
AVEO Announces Proposed Offering of Common Stock Mar 28 2017
AVEO (AVEO) Reports Narrower-than-Expected Loss in Q4 Mar 23 2017
AVEO reports 4Q loss Mar 22 2017
AVEO Reports Full Year 2016 Financial Results and Provides Business Update Mar 22 2017
AVEO Announces First Patient Dosed in Phase 1/2 TiNivo Trial of Tivozanib and Opdivo® (nivolumab)... Mar 22 2017
AVEO Pharmaceuticals (AVEO) Q4 Earnings: What's in Store? Mar 06 2017
Aveo Cancer Drug Tivozanib Clears Safety Review Feb 24 2017
AVEO Announces TIVO-3 Passes The First Safety Monitoring Committee Safety Review Feb 23 2017
AVEO Announces Clinical and Regulatory Updates for Tivozanib Feb 09 2017
AVEO to Present at the 19th Annual BIO CEO & Investor Conference Feb 06 2017
ETFs with exposure to AVEO Pharmaceuticals, Inc. : December 22, 2016 Dec 22 2016
How AVEO Pharmaceuticals, Inc. (AVEO) Stacks Up Against Its Peers? Dec 13 2016


Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK